CRIS Current Research Information System

PICCI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.613
AS - Asia 5.463
EU - Europa 4.067
SA - Sud America 354
AF - Africa 314
Continente sconosciuto - Info sul continente non disponibili 279
OC - Oceania 14
Totale 17.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.528
VN - Vietnam 1.582
SG - Singapore 1.517
CN - Cina 1.207
GB - Regno Unito 949
IT - Italia 656
DE - Germania 583
SE - Svezia 522
HK - Hong Kong 445
FR - Francia 273
RU - Federazione Russa 269
BR - Brasile 258
IN - India 238
IE - Irlanda 169
UA - Ucraina 148
JP - Giappone 105
CH - Svizzera 104
ZA - Sudafrica 102
NL - Olanda 97
CI - Costa d'Avorio 90
KR - Corea 73
BD - Bangladesh 68
EE - Estonia 65
TG - Togo 58
BG - Bulgaria 52
JO - Giordania 52
FI - Finlandia 45
CA - Canada 42
AR - Argentina 41
BE - Belgio 35
PH - Filippine 30
TH - Thailandia 26
ID - Indonesia 24
MX - Messico 24
ES - Italia 22
PL - Polonia 22
SC - Seychelles 22
IQ - Iraq 19
TR - Turchia 16
EC - Ecuador 15
GR - Grecia 14
AT - Austria 13
AU - Australia 13
TW - Taiwan 12
SA - Arabia Saudita 11
CL - Cile 10
CO - Colombia 10
UZ - Uzbekistan 9
MA - Marocco 7
PK - Pakistan 7
CR - Costa Rica 6
EG - Egitto 6
PE - Perù 6
AL - Albania 5
ET - Etiopia 5
LB - Libano 5
LT - Lituania 5
NG - Nigeria 5
UY - Uruguay 5
VE - Venezuela 5
DZ - Algeria 4
IR - Iran 4
PY - Paraguay 4
GT - Guatemala 3
HR - Croazia 3
MY - Malesia 3
RO - Romania 3
TN - Tunisia 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
Totale 16.823
Salva come PNG Salva come JPEG
Città #
Singapore 1.037
Southend 826
Ashburn 702
Fairfield 621
Chandler 520
San Jose 447
Hong Kong 428
Ho Chi Minh City 313
Woodbridge 309
Hanoi 304
Wilmington 293
Houston 283
Santa Clara 279
Seattle 266
Ann Arbor 263
Cambridge 239
Dong Ket 233
Princeton 229
Beijing 191
Dublin 170
Boardman 144
Hefei 126
Lauterbourg 111
Bern 92
Tokyo 91
Abidjan 90
Westminster 83
Nanjing 82
Jacksonville 78
Padova 77
Bologna 74
Los Angeles 74
Berlin 68
Turin 64
Seoul 59
Lomé 58
Amman 52
Buffalo 52
New York 52
Council Bluffs 49
Sofia 48
Bremen 46
Haiphong 44
Saint Petersburg 44
San Diego 44
Frankfurt am Main 41
Da Nang 38
Hebei 38
Helsinki 38
Redondo Beach 37
Dallas 36
Jinan 36
Falls Church 35
Shenyang 35
São Paulo 35
Brussels 34
Milan 34
Guangzhou 32
Changsha 30
Nanchang 30
Des Moines 26
London 23
Tianjin 23
Mülheim 22
Zhengzhou 21
Phoenix 20
Redmond 20
Falkenstein 19
Florence 19
Medford 19
Rome 19
Dearborn 18
Düsseldorf 18
Chicago 17
Shanghai 17
Shenzhen 17
Amsterdam 16
Nuremberg 16
Olalla 16
Warsaw 16
Bengaluru 15
Hải Dương 15
San Francisco 15
Brooklyn 14
Jiaxing 14
Munich 13
Biên Hòa 12
Can Tho 12
Chengdu 12
Jakarta 12
Ningbo 12
Thái Nguyên 12
Toronto 12
Atlanta 11
Johannesburg 11
Redwood City 11
The Dalles 11
Catanzaro 10
Haikou 10
Mexico City 10
Totale 10.910
Salva come PNG Salva come JPEG
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 325
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 253
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. 244
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 232
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 231
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. 224
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 224
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 221
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. 219
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 217
CD99 Acts as an Oncosuppressor in Osteosarcoma. 215
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 209
Clinical outcome of central conventional chondrosarcoma. 208
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 207
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 205
Spontaneous healing of an osteochondroma fracture. 204
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 202
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 200
Osteosarcoma follow-up: chest X-ray or computed tomography? 200
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 200
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 197
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 193
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 192
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. 191
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 191
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 183
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases 180
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 178
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 177
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 175
Small cell osteosarcoma: Clinicopathologic, immunohistochemical, and molecular analysis of 36 cases 173
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 172
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 171
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 171
Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 169
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 167
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 165
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 164
NVE-BEZ235 as a new therapeutic option for sarcomas. 164
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 163
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 162
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 161
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 160
Molecular diagnosis in ewing family tumors the rizzoli experience-222 consecutive cases in four years 157
Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma? 156
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 155
Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group 154
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 154
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 153
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 151
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 151
The natural history of advanced inoperable central chondrosarcoma 150
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 150
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol 149
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 148
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 147
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 147
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis 146
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 146
Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. 145
Pediatric chondrosarcomas: a retrospective review of 17 cases 145
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 144
Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999 143
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 143
Genetic and Molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes. 142
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 142
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 141
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? 139
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 138
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 137
Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity 136
Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature 136
Advances in Bone Metastases Management 135
Sacral Chordoma: Long-term outcome of a large series of patients surgically treated at two reference centers 134
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 133
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 133
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 132
Palliative therapy for osteosarcoma. 131
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study 131
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results 131
Osteosarcoma teleangectasico: analisi clinico-patologica di 87 casi 130
Epidemiology 130
Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. 129
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 128
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 127
Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma 126
Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, retrospective, multicenter study of the italian sarcoma group 123
Platelet-derived growth factors enhance proliferation of human stromal stem cells 122
Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients 121
Primary metastatic Ewing's family tumors:results of the Italian Sarcoma Group And Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. 117
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature 116
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series 116
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction 113
Reconstruction in the treatment of pelvic chondrosarcoma. 112
Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli 111
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups 109
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors. 107
Imaging of bone tumours for the musculoskeletal oncology surgeon. 105
Palliative treatment: selective arterial embolisation for bone metastases. 101
Dedifferentiated chondrosarcoma: preliminary results from the European Bone over 40 sarcomas study, (EURO.B.O.S.S.) 100
Totale 16.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.916 160 56 125 136 185 123 46 139 67 176 391 312
2022/20232.258 227 283 123 300 142 144 74 142 387 69 183 184
2023/2024479 23 107 41 37 22 75 40 40 14 26 23 31
2024/20252.212 106 354 191 135 388 99 132 77 19 169 76 466
2025/20265.433 480 568 435 386 576 304 502 310 1.147 374 201 150
2026/2027140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 17.104